rolipram has been researched along with Dyskinesia, Drug-Induced in 4 studies
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Haloperidol treatment significantly increased dyskinetic movements and striatal dopamine D2 receptor density compared with controls." | 1.29 | Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol. ( Fukui, S; Hashimoto, K; Inada, T; Iyo, M; Sasaki, H, 1995) |
| "This haloperidol treatment also induced a significantly increase in the frequency of involuntary chewing movements and tongue protrusions, which are considered as a model of tardive dyskinesia." | 1.29 | Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats. ( Fukui, S; Hashimoto, K; Inada, T; Iyo, M; Kitao, Y; Maeda, Y; Sasaki, H, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kanes, SJ | 1 |
| Tokarczyk, J | 1 |
| Siegel, SJ | 1 |
| Bilker, W | 1 |
| Abel, T | 1 |
| Kelly, MP | 1 |
| Sasaki, H | 2 |
| Hashimoto, K | 2 |
| Inada, T | 3 |
| Fukui, S | 2 |
| Iyo, M | 2 |
| Maeda, Y | 1 |
| Kitao, Y | 1 |
| Yagi, G | 1 |
1 review available for rolipram and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Current topics in tardive dyskinesia in Japan.
Topics: Antipsychotic Agents; Central Nervous System Agents; Ceruletide; Clinical Trials as Topic; Cross-Cul | 1995 |
3 other studies available for rolipram and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Rolipram: a specific phosphodiesterase 4 inhibitor with potential antipsychotic activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Acoustic Stimulation; Animals; Antipsychotic Agents; Behavior, | 2007 |
Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Antipsychotic Agents; Dep | 1995 |
Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Benzazepines; Dyskinesia, Drug-Induced; Haloperidol; M | 1995 |